The PE Ratio as of November 2025 (TTM) for Kairous Acquisition Corp. Limited (KACL) is 411.00

According to Kairous Acquisition Corp. Limited’s latest financial reports and current stock price. The company's current PE Ratio is 411.00. This represents a change of -598.83% compared to the average of -82.39 of the last 4 quarters.

Kairous Acquisition Corp. Limited (KACL) Historical PE Ratio (quarterly & annually)

How has KACL PE Ratio performed in the past?

The mean historical PE Ratio of Kairous Acquisition Corp. Limited over the last ten years is -103.00. The current 411.00 PE Ratio has changed -40003.18% with respect to the historical average. Over the past ten years (40 quarters), KACL's PE Ratio was at its highest in in the March 2023 quarter at 700.97. The PE Ratio was at its lowest in in the June 2022 quarter at -12543.82.

Kairous Acquisition Corp. Limited (KACL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kairous Acquisition Corp. Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kairous Acquisition Corp. Limited (KACL) Average PE Ratio

How has KACL PE Ratio performed in the past?

The current PE Ratio of Kairous Acquisition Corp. Limited (KACL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kairous Acquisition Corp. Limited (KACL) PE Ratio vs. Peers

How is KACL’s PE Ratio compared to its peers?

Kairous Acquisition Corp. Limited’s PE Ratio is less than DUET Acquisition Corp. (446.75), greater than Graphjet Technology (-0.25), greater than VSee Health, Inc. (-0.77), greater than GRIID Infrastructure Inc. Common Stock (-3.38), greater than Monterey Bio Acquisition Corporation (-25.14), greater than Atlantic Coastal Acquisition Corp. II (-622.87), greater than Acri Capital Acquisition Corporation (79.94), greater than Embrace Change Acquisition Corp. (184.27), greater than Eucrates Biomedical Acquisition Corp. (5.40), greater than TLGY Acquisition Corporation (-2.54),

Build a custom stock screener for Kairous Acquisition Corp. Limited (KACL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kairous Acquisition Corp. Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kairous Acquisition Corp. Limited (KACL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kairous Acquisition Corp. Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.